Skip to main content
Log in

Responses of peripheral endocannabinoids and endocannabinoid-related compounds to hedonic eating in obesity

  • Original Contribution
  • Published:
European Journal of Nutrition Aims and scope Submit manuscript

An Erratum to this article was published on 02 May 2016

Abstract

Purpose

Hedonic eating occurs independently from homeostatic needs prompting the ingestion of pleasurable foods that are typically rich in fat, sugar and/or salt content. In normal weight healthy subjects, we found that before hedonic eating, plasma levels of 2-arachidonoylglycerol (2-AG) were higher than before nonhedonic eating, and although they progressively decreased after food ingestion in both eating conditions, they were significantly higher in hedonic eating. Plasma levels of anandamide (AEA), oleoylethanolamide (OEA) and palmitoylethanolamide (PEA), instead, progressively decreased in both eating conditions without significant differences. In this study, we investigated the responses of AEA, 2-AG, OEA and PEA to hedonic eating in obese individuals.

Methods

Peripheral levels of AEA, 2-AG, OEA and PEA were measured in 14 obese patients after eating favourite (hedonic eating) and non-favourite (nonhedonic eating) foods in conditions of no homeostatic needs.

Results

Plasma levels of 2-AG increased after eating the favourite food, whereas they decreased after eating the non-favourite food, with the production of the endocannabinoid being significantly enhanced in hedonic eating. Plasma levels of AEA decreased progressively in nonhedonic eating, whereas they showed a decrease after the exposure to the favourite food followed by a return to baseline values after eating it. No significant differences emerged in plasma OEA and PEA responses to favourite and non-favourite food.

Conclusion

Present findings compared with those obtained in our previously studied normal weight healthy subjects suggest deranged responses of endocannabinoids to food-related reward in obesity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Lowe MR, Butryn ML (2007) Hedonic hunger: a new dimension of appetite? Physiol Behav 91:432–439

    Article  CAS  Google Scholar 

  2. Nummenmaa L, Hirvonen J, Hannukainen J, Immonen H, Lindroos M, Salminen P, Nuutila P (2012) Dorsal striatum and its limbic connectivity mediate abnormal anticipatory reward processing in obesity. PLoS One 7:e31089–e31089

    Article  CAS  Google Scholar 

  3. Swinburn B, Sacks G, Hall K, McPherson K, Finegood D, Moodie ML, Gortmaker SL (2011) The global obesity pandemic: shaped by global drivers and local environments. Lancet 378:804–814

    Article  Google Scholar 

  4. Volkow N, Wang G, Tomasi D, Baler R (2013) The addictive dimensionality of obesity. Biol Psychiatry 73:811–818

    Article  Google Scholar 

  5. Koob G, Volkow N (2010) Neurocircuitry of addiction. Neuropsychopharmacology 35:217–238

    Article  Google Scholar 

  6. Di Marzo V (2008) Targeting the endocannabinoid system: to enhance or reduce? Nat Rev Drug Discov 7:438–455

    Article  Google Scholar 

  7. Cristino L, Becker T, Di Marzo V (2014) Endocannabinoids and energy homeostasis: an update. Biofactors 40:389–397

    Article  CAS  Google Scholar 

  8. Lo Verme J, Gaetani S, Fu J, Oveisi F, Burton K, Piomelli D (2005) Regulation of food intake by oleoylethanolamide. Cell Mol Life Sci 62:708–716

    Article  CAS  Google Scholar 

  9. Movahed P, Jönsson BA, Birnir B, Wingstrand JA, Jørgensen TD, Ermund A, Sterner O, Zygmunt PM, Högestätt ED (2005) Endogenous unsaturated C18 N-acylethanolamines are vanilloid receptor (TRPV1) agonists. J Biol Chem 280:38496–38504

    Article  CAS  Google Scholar 

  10. Silvestri C, Di Marzo V (2013) The endocannabinoid system in energy homeostasis and the etiopathology of metabolic disorders. Cell Metab 17:475–490

    Article  CAS  Google Scholar 

  11. Adamczyk P, Miszkiel J, McCreary AC, Filip M, Papp M, Przegaliński E (2012) The effects of cannabinoid CB1, CB2 and vanilloid TRPV1 receptor antagonists on cocaine addictive behavior in rats. Brain Res 1444:45–54

    Article  CAS  Google Scholar 

  12. Melis M, Muntoni AL, Pistis M (2012) Endocannabinoids and the processing of value-related signals. Front Pharmacol 3:7

    Article  Google Scholar 

  13. Monteleone P, Matias I, Martiadis V, De Petrocellis L, Maj M, Di Marzo V (2005) Blood levels of the endocannabinoid anandamide are increased in anorexia nervosa and in binge-eating disorder, but not in bulimia nervosa. Neuropsychopharmacology 30:1216–1221

    Article  CAS  Google Scholar 

  14. Matias I, Gonthier MP, Orlando P, Martiadis V, De Petrocellis L, Cervino C, Petrosino S, Hoareau L, Festy F, Pasquali R, Roche R, Maj M, Pagotto U, Monteleone P, Di Marzo V (2006) Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia. J Clin Endocrinol Metab 91:3171–3180

    Article  CAS  Google Scholar 

  15. Monteleone P, Piscitelli F, Scognamiglio P, Monteleone AM, Canestrelli B, Di Marzo V, Maj M (2012) Hedonic eating is associated with increased peripheral levels of ghrelin and the endocannabinoid 2-arachidonoyl-glycerol in healthy humans: a pilot study. J Clin Endocrinol Metab 97:E917–E924

    Article  CAS  Google Scholar 

  16. World Health Organization (1998) Obesity: preventing and managing the global epidemic: report of a WHO consultation on obesity (WHO/NUT/NCD). WHO, Geneva

    Google Scholar 

  17. Annuzzi G, Piscitelli F, Di Marino L, Patti L, Giacco R, Costabile G, Bozzetto L, Riccardi G, Verde R, Petrosino S, Rivellese AA, Di Marzo V (2010) Differential alterations of the concentrations of endocannabinoids and related lipids in the subcutaneous adipose tissue of obese diabetic patients. Lipids Health Dis 9:43

    Article  Google Scholar 

  18. Dixon JW (1992) BMDP statistical software. Release 7.0. University of California Press, Berkeley

    Google Scholar 

  19. Melis T, Succu S, Sanna F, Boi A, Argiolas A, Melis MR (2007) The cannabinoid antagonist SR 141716A (Rimonabant) reduces the increase of extra-cellular dopamine release in the rat nucleus accumbens induced by a novel high palatable food. Neurosci Lett 419:231–235

    Article  CAS  Google Scholar 

  20. Di Marzo V (2011) Endocannabinoids: an appetite for fat. Proc Natl Acad Sci USA 108:12567–12568

    Article  Google Scholar 

  21. Piomelli D (2013) A fatty gut feeling. Trends Endocrinol Metab 24:332–341

    Article  CAS  Google Scholar 

  22. Erlanson-Albertsson C, Lindqvist A (2010) Fructose affects enzymes involved in the synthesis and degradation of hypothalamic endocannabinoids. Regul Pept 161:87–91

    Article  CAS  Google Scholar 

  23. Di Chiara G (2000) Role of dopamine in the behavioural actions of nicotine related to addiction. Eur J Pharmacol 393:295–314

    Article  Google Scholar 

  24. Burger KS, Stice E (2012) Frequent ice cream consumption is associated with reduced striatal response to receipt of an ice cream-based milkshake. Am J Clin Nutr 95:810–817

    Article  CAS  Google Scholar 

  25. Avena NM, Rada P, Hoebel BG (2008) Evidence for sugar addiction: behavioral and neurochemical effects of intermittent, excessive sugar intake. Neurosci Biobehav Rev 32:20–39

    Article  CAS  Google Scholar 

  26. Dagher A (2009) The neurobiology of appetite: hunger as addiction. Int J Obes (Lond) 33(Suppl 2):S30–S33

    Article  Google Scholar 

  27. Ziauddeen H, Farooqi IS, Fletcher PC (2012) Obesity and the brain: how convincing is the addiction model? Nat Rev Neurosci 13:279–286

    Article  CAS  Google Scholar 

  28. Mahler SV, Smith KS, Berridge KC (2007) Endocannabinoid hedonic hotspot for sensory pleasure: anandamide in nucleus accumbens shell enhances ‘liking’ of a sweet reward. Neuropsychopharmacology 32:2267–2278

    Article  CAS  Google Scholar 

  29. Smith KS, Mahler SV, Pecina S, Berridge KC (2010) Hedonic hotspots: generating sensory pleasure in the brain. In: Kringelbach ML, Berridge KC (eds) Pleasures of the Brain. Oxford University Press, Oxford, pp 27–49

    Google Scholar 

  30. Dalton M, Blundell J, Finlayson GS (2013) Examination of food reward and energy intake under laboratory and free-living conditions in a trait binge eating subtype of obesity. Front Psychol 4:1–8

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to V Di Marzo or P Monteleone.

Ethics declarations

Ethical standards

All the participants signed a written informed consent; the study was approved by the Ethics Committee of the University of Naples SUN; all the procedures were in accordance with the ethical standards laid down by the 1964 Declaration of Helsinki and its later amendments.

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Monteleone, A.M., Di Marzo, V., Monteleone, P. et al. Responses of peripheral endocannabinoids and endocannabinoid-related compounds to hedonic eating in obesity. Eur J Nutr 55, 1799–1805 (2016). https://doi.org/10.1007/s00394-016-1153-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00394-016-1153-9

Keywords

Navigation